Hubei, China
Business Type:
Trading Company
Year of Establishment:
Plant Area:
>2000 square meters
Management System Certification:
ISO 9001
Average Lead Time:
Peak season lead time: within 15 workday
Off season lead time: within 15 workday
OEM/ODM Service
Sample Available

Prl-8-53 HCl, Smarter Nootropics, Dietary Supplement manufacturer / supplier in China, offering Factory Price 99% Prl-8-53 HCl Dietary Supplement Smarter Nootropics 51352-87-5, Benzocaine Hydrochloride Local Anesthetic Benzocaine HCl CAS: 23239-88-5, Antiparasitic Agent Nitazoxanide CAS: 55981-09-4 Raw White Powder and so on.

Gold Member Since 2016
Supplier Homepage Products SARMs & Nootropic Powder Factory Price 99% Prl-8-53 HCl Dietary Supplement Smarter Nootropics 51352-87-5

Factory Price 99% Prl-8-53 HCl Dietary Supplement Smarter Nootropics 51352-87-5

Get Latest Price
Purchase Qty. / Reference FOB Price
100-499 g US $800
500-999 g US $3,500
1,000+ g US $6,400
Port: Shanghai, China
Production Capacity: 1000kg/Month
Payment Terms: T/T, Western Union, Money Gram
Powder: Yes
Customized: Non-Customized
Certification: ISO 9001
Suitable for: Adult
State: Solid
Purity: >99%

You Might Also Like


Basic Info

Model NO.: CAS: 51352-87-5
Model No.: CAS: 56-95-1
Shipment: EMS, FedEx, TNT, DHL
Payment: Western Union, Moneygram
Product Name: Chlorhexidine Acetate
Payment Terms: Western Union, Money Gram, Tt
Delivery: 5-7 Days Safe&Timely
Policy: Re-Shipping Policy
Grade: Pharmaceutical
Trademark: nanjjian
Transport Package: as Your Requiry
Specification: >99%
Origin: China
HS Code: 2933565412

Product Description

Factory Price 99% Prl-8-53 HCl Dietary Supplement Smarter Nootropics 51352-87-5

Chemical name:Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate
Synonyms:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride
CAS 51352-87-5
MW 319.82578
Dosage: Subjects in human trials have been given up to 100 mg a day and did not appear to develop any negative side effects


The effect of 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride (PRL-8-53) on learning and on retention of verbal information in human subjects was investigated. Using the serial anticipation method under double-blind conditions it was found that PRL-8-53 causes slight improvement of acquisition. Retinetion of verbal information was found improved to a statistically significant degree (most P values better than 0.01, some better than 0.001). No significant changes were found for either visual reaction time or motor control after drug when compared with placebo values.


PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%.


PRL-8-53's exact mechanisms of action are not well understood, but it is generally believed to regulate the brain's production of and response to several crucial neurotransmitters. In his reports on human and animal studies Hansl indicated that PRL-8-53 potentiates dopamine, partially restricts production of serotonin, and enhances the brain's response to acetylcholine.

Though Hansl's research report on the 1978 human study suggests those actions, it does not clearly delineate the mechanism of action.The fact that older subjects saw the most nootropic benefit from taking the drug supports the concept that dopamine modulation plays a major role in PLR-8-53's effects. Up-regulating the normal age-related lessening of dopamine production that is associated with cognitive decline could have a significant positive impact on both learning and memory.


The only human study on PRL-8-53 was based on the ingestion of a single 5 mg dose. There is no data on the effectiveness or potential toxicity of any other dosage in humans.


No adverse effects from a single 5 mg dose of PRL-8-53 were observed in the human study. Animal studies suggest that the compound has a high therapeutic threshold, but evidence is very limited because no comprehensive toxicity studies have been completed.

Related products :
Product nameCAS no:
DMHA (2-Aminoisoheptane)543-82-8

Other products :

Coluracetam 62613-82-5
Sunifiram 314728-85-3 
Unifiram 272786-64-8
Phenylpiracetam 7458-1-7
Pramiracetam Sulfate 72869-16-0
Pramiracetam 68497-62-1
Piracetam 7491-74-9
Oxiracetam 62613-82-5 
N-Methyl-D-aspartic Acid 6384-92-5 
Citicoline 987-78-0 
Phenibut 1078-21-3
Noopept 157115-85-0 
Alpha-GPC 28319-77-9
Aniracetam 72432-10-1
CDP-choline citicoline 987-78-0
Nefiracetam 77191-36-7
PRL-8-53 51352-87-5
IDR-21 22503-72-6
NSI-189 1270138-41-4

Send your message to this supplier

avatar Ms. Sunny

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now